117 related articles for article (PubMed ID: 1937363)
1. Immunohistochemical detection of ras p21 and c-myc p62 in colonic adenomas and carcinomas.
Agnantis NJ; Apostolikas N; Sficas C; Zolota V; Spandidos DA
Hepatogastroenterology; 1991 Jun; 38(3):239-42. PubMed ID: 1937363
[TBL] [Abstract][Full Text] [Related]
2. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
4. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
[TBL] [Abstract][Full Text] [Related]
6. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
[TBL] [Abstract][Full Text] [Related]
7. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
10. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
[TBL] [Abstract][Full Text] [Related]
11. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.
Melhem MF; Meisler AI; Finley GG; Bryce WH; Jones MO; Tribby II; Pipas JM; Koski RA
Cancer Res; 1992 Nov; 52(21):5853-64. PubMed ID: 1394214
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of expression of p21 and c-myc protein in hepatocellular carcinoma with pericarcinomatous liver tissue].
Feng D; Cheng R; Yan Y
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):310-2. PubMed ID: 9868083
[TBL] [Abstract][Full Text] [Related]
13. High c-myc protein expression in benign colorectal lesions correlates with the degree of dysplasia.
Pavelic ZP; Pavelic L; Kuvelkar R; Gapany SR
Anticancer Res; 1992; 12(1):171-5. PubMed ID: 1567165
[TBL] [Abstract][Full Text] [Related]
14. [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products].
Roa I; Araya JC; Shiraishi T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X
Rev Med Chil; 1994 Jul; 122(7):754-9. PubMed ID: 7732224
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.
Spandidos DA; Pintzas A; Kakkanas A; Yiagnisis M; Mahera H; Patra E; Agnantis NJ
Anticancer Res; 1987; 7(6):1299-304. PubMed ID: 3327455
[TBL] [Abstract][Full Text] [Related]
16. Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon.
Flohil CC; Janssen PA; Bosman FT
J Pathol; 1996 Apr; 178(4):393-7. PubMed ID: 8691316
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin.
Pavlidis N; Briassoulis E; Bai M; Fountzilas G; Agnantis N
Anticancer Res; 1995; 15(6B):2563-7. PubMed ID: 8669824
[TBL] [Abstract][Full Text] [Related]
19. Cellular localisation of c-myc product in human colorectal epithelial neoplasia.
Royds JA; Sharrard RM; Wagner B; Polacarz SV
J Pathol; 1992 Mar; 166(3):225-33. PubMed ID: 1381423
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of oncogene product expression in human lung cancer].
Dosaka-Akita H; Harada M; Miyamoto H; Kawakami Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1441-7. PubMed ID: 1331597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]